DrugPatentWatch Database Preview
Intercept Pharms Inc Company Profile
What is the competitive landscape for INTERCEPT PHARMS INC, and what generic alternatives to INTERCEPT PHARMS INC drugs are available?
INTERCEPT PHARMS INC has one approved drug.
There are five US patents protecting INTERCEPT PHARMS INC drugs.
There are sixty-two patent family members on INTERCEPT PHARMS INC drugs in twenty-eight countries and six supplementary protection certificates in five countries.
Summary for Intercept Pharms Inc
| International Patents: | 62 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Intercept Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-001 | May 27, 2016 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-001 | May 27, 2016 | RX | Yes | No | 7,138,390 | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | ||
| Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-002 | May 27, 2016 | RX | Yes | Yes | 7,138,390 | ➤ Try a Free Trial | Y | Y | ➤ Try a Free Trial | ||
| Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-002 | May 27, 2016 | RX | Yes | Yes | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-001 | May 27, 2016 | RX | Yes | No | ➤ Try a Free Trial | ➤ Try a Free Trial | |||||
| Intercept Pharms Inc | OCALIVA | obeticholic acid | TABLET;ORAL | 207999-001 | May 27, 2016 | RX | Yes | No | 8,058,267 | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for Intercept Pharms Inc Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Taiwan | 201703773 | ➤ Try a Free Trial |
| European Patent Office | 1392714 | ➤ Try a Free Trial |
| Colombia | 2017011535 | ➤ Try a Free Trial |
| Colombia | 7240414 | ➤ Try a Free Trial |
| Japan | 2004519492 | ➤ Try a Free Trial |
| Philippines | 12014502835 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for Intercept Pharms Inc Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| /2017 | Austria | ➤ Try a Free Trial | PRODUCT NAME: OBETICHOLSAEURE, DESSEN PHARMAZEUTISCH AKZEPTABLEN SALZE, SOLVATE ODER AMINOSAEURE-KONJUGATE; REGISTRATION NO/DATE: EU/1/16/1139 20161212 |
| 90020-0 | Sweden | ➤ Try a Free Trial | PRODUCT NAME: OBETICHOLIC ACID; REG. NO/DATE: EU/1/16/1139 20161215 |
| 2017 00025 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: OBETICHOLIC ACID; REG. NO/DATE: EU/1/16/1139 20161215 |
| 2017 00025 | Denmark | ➤ Try a Free Trial | PRODUCT NAME: OBETICHOLIC ACID; REG. NO/DATE: EU/1/16/1139 20161215 |
| 2017000034 | Germany | ➤ Try a Free Trial | PRODUCT NAME: OBETICHOLSAEURE (OBETICHOLIC ACID); REGISTRATION NO/DATE: EU/1/16/1139 20161212 |
| 0877 | Netherlands | ➤ Try a Free Trial | PRODUCT NAME: OBETICHOLZUUR; REGISTRATION NO/DATE: EU/1/16/1139 20161215 |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
